Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718884 | SCV000515013 | likely benign | not provided | 2018-05-21 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17304050, 10732801) |
Labcorp Genetics |
RCV000457035 | SCV000556651 | benign | Tuberous sclerosis 2 | 2024-11-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001017062 | SCV001178086 | likely benign | Hereditary cancer-predisposing syndrome | 2019-01-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000457035 | SCV002041291 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001017062 | SCV002532739 | likely benign | Hereditary cancer-predisposing syndrome | 2021-09-01 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV003995990 | SCV004817062 | likely benign | Tuberous sclerosis syndrome | 2023-12-18 | criteria provided, single submitter | clinical testing |